Cirsium Biosciences

About Cirsium Biosciences

Cirsium Biosciences is focused on democratizing gene therapy through transformative manufacturing methods. Their mission is to eliminate current manufacturing bottlenecks in gene therapy by using innovative platforms that enhance production capacity and scalability.

Products & Services

Plant-Based Bioreactor Platform:A highly scalable, rapid, cost-effective, and safe platform for viral vector production using whole plants as bioreactors. It addresses issues like production capacity, scalability, high costs, and standardization, achieving up to 70% reduction in manufacturing lead times and significant cost reductions compared to traditional methods.

Specialties

Gene Therapy Manufacturing Viral Vector Production Plant-Based Bioreactors Scalable Production Methods

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: ARPA-H Funding T: - FT: ARPA-H Funding	A: 61000000 MR: - FA: up to $61 million FAN: 61000000	D: 2024-10-11 FD: 2024-10-11	1 investors

ARPA-H Funding Latest

2024-10-11

$61.0M

1 investor (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

D

Daniel Gibbs

Chief Executive Officer & Co-Founder

J

Jake Connors

Chief Technology Officer & Co-Founder

P

Pranav Mathur

Director of R&D

Q

Qingqing Xie

Principal Scientist

K

Kevin Wong

Scientist I

T

Terri Grider

Lab Manager

View 18 more team members with Pro

Unlock Full Team Directory

Recent News